Quantbot Technologies’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
DGI
C
FCM
Quantbot Technologies's TVRD Position: Q2 2024 in Review
Quantbot Technologies sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 240 shares — an estimated $7.88K sold.
Quantbot Technologies first reported a position in TVRD in Q1 2016 and held it in 16 quarters. The position peaked at $160K in Q4 2021. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.
- Quantbot Technologies reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
- Quantbot Technologies sold 240 Tvardi Therapeutics shares in Q2 2024, an estimated $7.88K.
- Quantbot Technologies first reported a position in Tvardi Therapeutics in Q1 2016 and held it in 16 quarters.
- Quantbot Technologies's Tvardi Therapeutics position peaked at $160K in Q4 2021.
- 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.
Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.